loadpatents
Patent applications and USPTO patent grants for Viklund; Jenny.The latest application filed is for "pyridylpyridone compounds".
Patent | Date |
---|---|
Pyridylpyridone Compounds App 20220218688 - Lindstrom; Johan ;   et al. | 2022-07-14 |
Pyridinamine-pyridone And Pyrimidinamine-pyridone Compounds App 20220177495 - Lindstrom; Johan ;   et al. | 2022-06-09 |
6-heterocyclyl-4-morpholin-4-ylpyridine-2-one Compounds Useful For The Treatment Of Cancer And Diabetes App 20220175788 - Martinsson; Jessica ;   et al. | 2022-06-09 |
6-aryl-4-morpholin-1-ylpyridone Compounds Useful For The Treatment Of Cancer And Diabetes App 20220117974 - MARTINSSON; Jessica ;   et al. | 2022-04-21 |
Pyridylpyridone compounds Grant 11,219,618 - Lindstrom , et al. January 11, 2 | 2022-01-11 |
Pyridinamine-pyridone and pyrimidinamine- pyridone compounds Grant 11,208,423 - Lindstrom , et al. December 28, 2 | 2021-12-28 |
6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes Grant 11,179,399 - Martinsson , et al. November 23, 2 | 2021-11-23 |
Aminopyridine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20210317136 - LINDSTROM; Johan ;   et al. | 2021-10-14 |
Chromenopyridine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20210253600 - LINDSTROM; Johan ;   et al. | 2021-08-19 |
6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes Grant 11,077,113 - Martinsson , et al. August 3, 2 | 2021-08-03 |
6-heterocyclyl-4-morpholin-4-ylpyridine-2-one Compounds Useful For The Treatment Of Cancer And Diabetes App 20210161906 - MARTINSSON; Jessica ;   et al. | 2021-06-03 |
6-heterocyclyl-4-morpholin-4-ylpyridine-2-one Compounds Useful For The Treatment Of Cancer And Diabetes App 20210128571 - MARTINESSON; Jessica ;   et al. | 2021-05-06 |
Azaindolylpyridone And Diazaindolylpyridone Compounds App 20210122745 - LINDSTROM; Johan ;   et al. | 2021-04-29 |
Morpholinylpyridone Compounds App 20200361922 - LINDSTROM; Johan ;   et al. | 2020-11-19 |
Pyridinamine-pyridone And Pyrimidinamine-pyridone Compounds App 20200361963 - LINDSTROM; Johan ;   et al. | 2020-11-19 |
Aryl-bipyridine Amine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20200331913 - LINDSTROM; Johan ;   et al. | 2020-10-22 |
Pyridylpyridone Compounds App 20200289496 - LINDSTROM; Johan ;   et al. | 2020-09-17 |
Mono-fluoro beta-secretase inhibitors Grant 9,650,336 - Minidis , et al. May 16, 2 | 2017-05-16 |
Bis-(sulfonylamino) derivatives for use in therapy Grant 9,145,380 - Bylund , et al. September 29, 2 | 2015-09-29 |
Mono-fluoro Beta-secretase Inhibitors App 20140288091 - Minidis; Anna ;   et al. | 2014-09-25 |
Thioxanthine derivatives and their use as inhibitors of MPO Grant 8,026,244 - Tiden , et al. September 27, 2 | 2011-09-27 |
New Compounds Useful for Treating CNS Disorders App 20110098292 - Malmstrom; Jonas ;   et al. | 2011-04-28 |
Bis-(Sulfonylamino) Derivatives in Therapy 066 App 20110021540 - Bylund; Johan ;   et al. | 2011-01-27 |
Bis-(Sulfonylamino) derivatives for use in therapy App 20100331321 - Bylund; Johan ;   et al. | 2010-12-30 |
Thioxanthine Derivatives and Their Use as Inhibitors of MPO App 20090286813 - Pivonka; Donald ;   et al. | 2009-11-19 |
Bis-(Sulfonylamino) Derivatives in Therapy 066 App 20090281138 - Bylund; Johan ;   et al. | 2009-11-12 |
Benzoic Acid Derivatives that are Modulators or Agonists of GlyR App 20090192190 - Gyback; Helena ;   et al. | 2009-07-30 |
Bis-(Sulfonylamino) Derivatives in Therapy 205 App 20090163586 - Bylund; Johan ;   et al. | 2009-06-25 |
Thioxanthine Derivatives and Their Use as Inhibitors of MPO App 20090149475 - Tiden; Anna-Karin ;   et al. | 2009-06-11 |
Bis-(Sulfonylamino) Derivatives in Therapy 065 App 20090131468 - Bylund; Johan ;   et al. | 2009-05-21 |
Novel Use App 20080096929 - Tiden; Anna-Karin ;   et al. | 2008-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.